Skip Navigation



Journal of the National Cancer Institute Advance Access published online on April 29, 2008
JNCI Journal of the National Cancer Institute, doi:10.1093/jnci/djn108
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
100/9/680-a    most recent
djn108v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Gennari, A.
Right arrow Articles by Bruzzi, P.
PubMed
Right arrow Articles by Gennari, A.
Right arrow Articles by Bruzzi, P.
Related Collections
Right arrowRelated Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press.

CORRESPONDENCE

Response:Re: HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials

Alessandra Gennari, Maria Pia Sormani, Paolo Pronzato, Paolo Bruzzi

Affiliations of authors: Department of Clinical Epidemiology and Medical Oncology, National Cancer Research Institute, Genoa, Italy (AG, PP, PB); Department of Health Sciences, University of Genoa, Italy (AG, MPS)

Correspondence to: Alessandra Gennari, MD, PhD, National Cancer Research Institute, Largo Rosanna Benzi, 10 16132 Genoa, Italy (e-mail: alessandra.gennari@istge.it).

The first 10% of the full text of this article appears below.

Dr Mehta correctly points out that there may be subgroups of HER2-negative patients who would benefit from the use of anthracycline-containing adjuvant chemotherapy, and she suggests that some anthracycline-containing regimens (especially the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Correspondence

Re: HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials
Rita S. Mehta and Toni Schubbert
J Natl Cancer Inst 2008 100: 680. [Extract] [Full Text] [PDF]